Figure 5From: Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patientsELISA experiment with sera from lung cancer patients. Two negative sera and two positive sera for producing p53 autoantibody proven by Western blot analysis (as shown in Figure 4) at 1:200 dilution were subjected to react with the purified (His)6-p53 recombinant proteins at concentration of 0, 1 and 3 μg/ml immobilized onto un-modified microplate along with crude lysate containing (His)6-p53 fusion protein (A), or crude lysate containing (His)6-p53 recombinant proteins directly immobilized onto nickel coated microplate at concentration of 0, 100, 200 μg/ml along with negative cell lysate control from pET15b(+) empty vector transformed cells (B), and crude lysate containing biotinylated p53-BCCP fusion proteins immobilized onto avidin-coated microplate at concentration of 0, 100, 200 μg/ml along with biotinylated CD147-BCCP containing cell lysate as a negative control (C) Experiment was done in triplicate and error bar represent standard deviation.Back to article page